What we have learned from the optic neuritis treatment trial.
Tanaka
G H
GH
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015331:Cohort Studies; D006801:Humans; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009902:Optic Neuritis / Q000188:drug therapy*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000379:methods
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone